{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T08:06:09Z","timestamp":1789632369681,"version":"build-2803163510"},"reference-count":77,"publisher":"Portland Press Ltd.","license":[{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"EPSRC Molecular Sciences for Medicine Centre for Doctoral Training","award":["EP\/S022791\/1"],"award-info":[{"award-number":["EP\/S022791\/1"]}]},{"name":"European Commission","award":["101003111"],"award-info":[{"award-number":["101003111"]}]}],"content-domain":{"domain":["portlandpress.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The present review provides a concise overview of cyclic peptides as chemical probes, including recent developments in their discovery and applications. Their \u2018goldilocks\u2019 physicochemical properties, selectivity, and affinity, as well as their range of discovery techniques and modular structure, position them as compelling tools within the chemical biology landscape. The selectivity and modularity of peptides in particular enable their adaptation into chemical tools and facilitate the exploration of their targets, as demonstrated by recent examples discussed herein. Given the growing interest in this area, the present review highlights selected examples from a rapidly expanding literature, reflecting the strength and versatility of this modality. As the field continues to mature, we can expect cyclic peptides to enable the exploration and validation of previously intractable targets and to support drug discovery efforts against novel targets. Notable challenges remain, particularly regarding cell permeability, although active research continues to advance the area. Cyclic peptides are well-placed to serve as a powerful complement to the existing chemical biology toolbox.<\/jats:p>","DOI":"10.1042\/ebc20260008","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T07:49:03Z","timestamp":1789631343000},"update-policy":"https:\/\/doi.org\/10.1042\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Expanding the chemical biology toolbox: cyclic peptides emerging as versatile chemical probes"],"prefix":"10.1042","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-3905-4012","authenticated-orcid":false,"given":"Keir\u00a0H.","family":"Pebody","sequence":"first","affiliation":[{"name":"Chemistry - School of Natural and Environmental Sciences, Newcastle University, Newcastle upon Tyne, NE1 7RU, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1169-5082","authenticated-orcid":false,"given":"Akane","family":"Kawamura","sequence":"additional","affiliation":[{"name":"Chemistry - School of Natural and Environmental Sciences, Newcastle University, Newcastle upon Tyne, NE1 7RU, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"288","published-online":{"date-parts":[[2026,9,17]]},"reference":[{"key":"2026091703485609900_B1","article-title":"Structural Genomics Consortium, Chemical Probes"},{"key":"2026091703485609900_B2","article-title":"Chemical Probes Portal"},{"key":"2026091703485609900_B3","doi-asserted-by":"publisher","first-page":"1652445","DOI":"10.3389\/fphar.2025.1652445","article-title":"Editorial: Exploring small molecule probes: advancements and applications in pharmacological research","volume":"16","author":"Yeh","year":"2025","journal-title":"Front. Pharmacol."},{"key":"2026091703485609900_B4","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.cbpa.2016.05.015","article-title":"Monoclonal antibody-based optical molecular imaging probes; considerations and caveats in chemistry, biology and pharmacology","volume":"33","author":"Kobayashi","year":"2016","journal-title":"Curr. Opin. Chem. Biol."},{"key":"2026091703485609900_B5","doi-asserted-by":"publisher","first-page":"103891","DOI":"10.1016\/j.drudis.2024.103891","article-title":"Drugging the entire human proteome: are we there yet?","volume":"29","author":"Smith","year":"2024","journal-title":"Drug Discov. Today"},{"key":"2026091703485609900_B6","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.3389\/fphar.2018.01208","article-title":"Targeted intracellular delivery of antibodies: the state of the art","volume":"9","author":"Slastnikova","year":"2018","journal-title":"Front. Pharmacol."},{"key":"2026091703485609900_B7","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.freeradbiomed.2021.09.005","article-title":"Nanobodies\u2014little helpers unravelling intracellular signaling","volume":"176","author":"Wagner","year":"2021","journal-title":"Free Radic. Biol. Med."},{"key":"2026091703485609900_B8","doi-asserted-by":"publisher","first-page":"eaag1166","DOI":"10.1126\/scitranslmed.aag1166","article-title":"The druggable genome and support for target identification and validation in drug development","volume":"9","author":"Finan","year":"2017","journal-title":"Sci. Transl.Med."},{"key":"2026091703485609900_B9","doi-asserted-by":"publisher","first-page":"7971","DOI":"10.1039\/D2CS00478J","article-title":"PROTAC degraders as chemical probes for studying target biology and target validation","volume":"51","author":"Nemec","year":"2022","journal-title":"Chem. Soc. Rev."},{"key":"2026091703485609900_B10","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1038\/nature18002","article-title":"Proteome-wide covalent ligand discovery in native biological systems","volume":"534","author":"Backus","year":"2016","journal-title":"Nature"},{"key":"2026091703485609900_B11","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1021\/acsmedchemlett.9b00582","article-title":"New chemical modalities and strategic thinking in early drug discovery","volume":"11","author":"Blanco","year":"2020","journal-title":"ACS Med. Chem. Lett."},{"key":"2026091703485609900_B12","doi-asserted-by":"publisher","first-page":"10241","DOI":"10.1021\/acs.chemrev.9b00008","article-title":"Understanding cell penetration of cyclic peptides","volume":"119","author":"Dougherty","year":"2019","journal-title":"Chem. Rev."},{"key":"2026091703485609900_B13","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.tips.2023.04.003","article-title":"Recent advances in the development of therapeutic peptides","volume":"44","author":"Fetse","year":"2023","journal-title":"Trends Pharmacol. Sci."},{"key":"2026091703485609900_B14","doi-asserted-by":"publisher","first-page":"e202308251","DOI":"10.1002\/ange.202308251","article-title":"Cyclic peptides for drug development","volume":"136","author":"Ji","year":"2024","journal-title":"Angew. Chem."},{"key":"2026091703485609900_B15","doi-asserted-by":"publisher","first-page":"13131","DOI":"10.1021\/acs.jmedchem.1c00580","article-title":"Cyclosporin structure and permeability: from A to Z and beyond","volume":"64","author":"Corbett","year":"2021","journal-title":"J. Med. Chem."},{"key":"2026091703485609900_B16","doi-asserted-by":"publisher","first-page":"16610","DOI":"10.1021\/jacs.3c03886","article-title":"Development of orally bioavailable peptides targeting an intracellular protein: from a hit to a clinical KRAS inhibitor","volume":"145","author":"Tanada","year":"2023","journal-title":"J. Am. Chem. Soc."},{"key":"2026091703485609900_B17","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1161\/CIRCULATIONAHA.122.063372","article-title":"Orally bioavailable macrocyclic peptide that inhibits binding of PCSK9 to the low density lipoprotein receptor","volume":"148","author":"Johns","year":"2023","journal-title":"Circulation"},{"key":"2026091703485609900_B18","article-title":"Trends for cyclic peptides in drug discovery","author":"CAS Insights","year":"2026"},{"key":"2026091703485609900_B19","doi-asserted-by":"publisher","first-page":"17515","DOI":"10.1038\/s41598-024-67371-5","article-title":"JNJ-77242113, a highly potent, selective peptide targeting the IL-23 receptor, provides robust IL-23 pathway inhibition upon oral dosing in rats and humans","volume":"14","author":"Fourie","year":"2024","journal-title":"Sci. Rep."},{"key":"2026091703485609900_B20","doi-asserted-by":"publisher","first-page":"25772","DOI":"10.1021\/acs.jmedchem.5c02537","article-title":"Discovery of zilucoplan: a complement C5 inhibitor for treatment of anti-acetylcholine receptor (AChR) antibody-positive generalized myasthenia gravis (gMG)","volume":"68","author":"Ye","year":"2025","journal-title":"J. Med. Chem."},{"key":"2026091703485609900_B21","doi-asserted-by":"publisher","first-page":"11913","DOI":"10.1021\/acs.jmedchem.2c01077","article-title":"Cyclic peptide screening methods for preclinical drug discovery","volume":"65","author":"Li","year":"2022","journal-title":"J. Med. Chem."},{"key":"2026091703485609900_B22","doi-asserted-by":"publisher","first-page":"19129","DOI":"10.1021\/jacs.3c04899","article-title":"Advances in ultrahigh throughput hit discovery with tandem mass spectrometry encoded libraries","volume":"145","author":"Mata","year":"2023","journal-title":"J. Am. Chem. Soc."},{"key":"2026091703485609900_B23","doi-asserted-by":"publisher","first-page":"eadr1018","DOI":"10.1126\/sciadv.adr1018","article-title":"Affinity selection\u2013mass spectrometry with linearizable macrocyclic peptide libraries","volume":"11","author":"Lee","year":"2025","journal-title":"Sci. Adv."},{"key":"2026091703485609900_B24","doi-asserted-by":"publisher","first-page":"4007","DOI":"10.1002\/anie.201600077","article-title":"High-throughput measurement of binding kinetics by mRNA display and next-generation sequencing","volume":"55","author":"Jalali-Yazdi","year":"2016","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"2026091703485609900_B25","doi-asserted-by":"publisher","first-page":"32451","DOI":"10.1021\/jacs.6c09188","article-title":"Identification of antibacterial cyclic peptides with a high-throughput cell-based dropout screen","volume":"148","author":"Windeln","year":"2026","journal-title":"J. Am. Chem. Soc."},{"key":"2026091703485609900_B26","doi-asserted-by":"publisher","first-page":"11725","DOI":"10.1039\/D3CS01066J","article-title":"Recent advances in peptide macrocyclization strategies","volume":"53","author":"Fang","year":"2024","journal-title":"Chem. Soc. Rev."},{"key":"2026091703485609900_B27","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1038\/s41589-026-02237-7","article-title":"Generation of membrane-permeable cyclic peptides inhibiting protein\u2013protein interaction","volume":"22","author":"Ji","year":"2026","journal-title":"Nat. Chem. Biol."},{"key":"2026091703485609900_B28","doi-asserted-by":"publisher","first-page":"449","DOI":"10.2174\/1389201017666160114095553","article-title":"Latest advances in OBOC peptide libraries. improvements in screening strategies and enlarging the family from linear to cyclic libraries","volume":"17","author":"Martinez-Ceron","year":"2016","journal-title":"Curr. Pharm. Biotechnol."},{"key":"2026091703485609900_B29","doi-asserted-by":"publisher","first-page":"5072","DOI":"10.1021\/acs.jmedchem.2c00010","article-title":"A new amino acid for improving permeability and solubility in macrocyclic peptides through side chain-to-backbone hydrogen bonding","volume":"65","author":"Taechalertpaisarn","year":"2022","journal-title":"J. Med. Chem."},{"key":"2026091703485609900_B30","doi-asserted-by":"publisher","first-page":"311","DOI":"10.3390\/md19060311","article-title":"Improvement on permeability of cyclic peptide\/peptidomimetic: backbone N-methylation as a useful tool","volume":"19","author":"Li","year":"2021","journal-title":"Marine Drugs"},{"key":"2026091703485609900_B31","doi-asserted-by":"publisher","first-page":"6050","DOI":"10.1038\/s41467-023-41748-y","article-title":"An amide to thioamide substitution improves the permeability and bioavailability of macrocyclic peptides","volume":"14","author":"Ghosh","year":"2023","journal-title":"Nat. Commun."},{"key":"2026091703485609900_B32","doi-asserted-by":"publisher","first-page":"6929","DOI":"10.1021\/acs.jmedchem.5c03165","article-title":"Helicogenic amino acid increases passive permeability and oral bioavailability of macrocycles by preorganizing \u03b3-turn","volume":"69","author":"Raj","year":"2026","journal-title":"J. Med. Chem."},{"key":"2026091703485609900_B33","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1038\/s42004-024-01388-9","article-title":"Discovering covalent cyclic peptide inhibitors of peptidyl arginine deiminase 4 (PADI4) using mRNA-display with a genetically encoded electrophilic warhead","volume":"7","author":"Mathiesen","year":"2024","journal-title":"Commun. Chem."},{"key":"2026091703485609900_B34","doi-asserted-by":"publisher","first-page":"15065","DOI":"10.1021\/jacs.3c04833","article-title":"Identification of covalent cyclic peptide inhibitors in mRNA display","volume":"145","author":"Iskandar","year":"2023","journal-title":"J. Am. Chem. Soc."},{"key":"2026091703485609900_B35","doi-asserted-by":"publisher","first-page":"7461","DOI":"10.1021\/jacs.4c15843","article-title":"Identification of covalent cyclic peptide inhibitors targeting protein\u2013protein interactions using phage display","volume":"147","author":"Wang","year":"2025","journal-title":"J. Am. Chem. Soc."},{"key":"2026091703485609900_B36","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1021\/acschembio.3c00297","article-title":"Phage display of two distinct warheads to inhibit challenging proteins","volume":"18","author":"Zheng","year":"2023","journal-title":"ACS Chem. Biol."},{"key":"2026091703485609900_B37","doi-asserted-by":"publisher","first-page":"6051","DOI":"10.1021\/acs.chemrev.4c00004","article-title":"Diversification of phage-displayed peptide libraries with noncanonical amino acid mutagenesis and chemical modification","volume":"124","author":"Hampton","year":"2024","journal-title":"Chem. Rev."},{"key":"2026091703485609900_B38","doi-asserted-by":"publisher","first-page":"12213","DOI":"10.1021\/acs.chemrev.4c00422","article-title":"Selection of nucleotide-encoded mass libraries of macrocyclic peptides for inaccessible drug targets","volume":"124","author":"Colas","year":"2024","journal-title":"Chem. Rev."},{"key":"2026091703485609900_B39","doi-asserted-by":"publisher","first-page":"e202422673","DOI":"10.1002\/anie.202422673","article-title":"Macrocyclic peptide probes for immunomodulatory protein CD59: potent modulators of bacterial toxin activity and antibody-dependent cytotoxicity","volume":"64","author":"Bickel","year":"2025","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"2026091703485609900_B40","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1021\/acschembio.4c00083","article-title":"mRNA display identifies potent, paralog-selective peptidic ligands for ARID1B","volume":"19","author":"Cremosnik","year":"2024","journal-title":"ACS Chem. Biol."},{"key":"2026091703485609900_B41","doi-asserted-by":"publisher","first-page":"10959","DOI":"10.1073\/pnas.1809901115","article-title":"Nonproteinogenic deep mutational scanning of linear and cyclic peptides","volume":"115","author":"Rogers","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2026091703485609900_B42","doi-asserted-by":"publisher","first-page":"9746","DOI":"10.1038\/s41467-024-53554-1","article-title":"A cyclic peptide toolkit reveals mechanistic principles of peptidylarginine deiminase IV regulation","volume":"15","author":"Bertran","year":"2024","journal-title":"Nat. Commun."},{"key":"2026091703485609900_B43","doi-asserted-by":"publisher","first-page":"e202215671","DOI":"10.1002\/anie.202215671","article-title":"Potent de novo macrocyclic peptides that inhibit O-GlcNAc transferase through an allosteric mechanism","volume":"62","author":"Alteen","year":"2023","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"2026091703485609900_B44","doi-asserted-by":"publisher","first-page":"3256","DOI":"10.1039\/D1SC06844J","article-title":"An integrated platform approach enables discovery of potent, selective and ligand-competitive cyclic peptides targeting the GIP receptor","volume":"13","author":"Bhushan","year":"2022","journal-title":"Chem. Sci."},{"key":"2026091703485609900_B45","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1039\/D3CB00168G","article-title":"Identification and engineering of potent cyclic peptides with selective or promiscuous binding through biochemical profiling and bioinformatic data analysis","volume":"5","author":"Smith","year":"2024","journal-title":"RSC Chem. Biol."},{"key":"2026091703485609900_B46","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1042\/BCJ20250283","article-title":"De novo cyclic peptides allow visualisation of the monomeric and functional amyloid conformations of the kinase RIPK3","volume":"483","author":"Buchanan","year":"2026","journal-title":"Biochemical J."},{"key":"2026091703485609900_B47","doi-asserted-by":"publisher","first-page":"4569","DOI":"10.1039\/C8SC00286J","article-title":"Non-competitive cyclic peptides for targeting enzyme\u2013substrate complexes","volume":"9","author":"McAllister","year":"2018","journal-title":"Chem. Sci."},{"key":"2026091703485609900_B48","doi-asserted-by":"publisher","first-page":"8312","DOI":"10.1021\/jacs.4c15713","article-title":"An mRNA Display approach for covalent targeting of a Staphylococcus aureus virulence factor","volume":"147","author":"Wang","year":"2025","journal-title":"J. Am. Chem. Soc."},{"key":"2026091703485609900_B49","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1038\/s41589-019-0285-7","article-title":"Macrocyclic peptide-based inhibition and imaging of hepatocyte growth factor","volume":"15","author":"Sakai","year":"2019","journal-title":"Nat. Chem. Biol."},{"key":"2026091703485609900_B50","doi-asserted-by":"publisher","first-page":"e2520462123","DOI":"10.1073\/pnas.2520462123","article-title":"High-affinity, structure-validated and selective macrocyclic peptide tools for chemical biology studies of Huntingtin","volume":"123","author":"Fanti","year":"2026","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2026091703485609900_B51","doi-asserted-by":"publisher","first-page":"7136","DOI":"10.1039\/D2SC05944D","article-title":"Cyclic peptides target the aromatic cage of a PHD-finger reader domain to modulate epigenetic protein function","volume":"14","author":"Coleman","year":"2023","journal-title":"Chem. Sci."},{"key":"2026091703485609900_B52","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1021\/ja0693587","article-title":"Reactivation of the p53 tumor suppressor pathway by a stapled p53 peptide","volume":"129","author":"Bernal","year":"2007","journal-title":"J. Am. Chem. Soc."},{"key":"2026091703485609900_B53","doi-asserted-by":"publisher","first-page":"11801","DOI":"10.1002\/anie.201906791","article-title":"Engineered peptide macrocycles can inhibit matrix metalloproteinases with high selectivity","volume":"58","author":"Maola","year":"2019","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"2026091703485609900_B54","doi-asserted-by":"publisher","first-page":"717","DOI":"10.3390\/biom10050717","article-title":"Challenges in matrix metalloproteinases inhibition","volume":"10","author":"Laronha","year":"2020","journal-title":"Biomolecules"},{"key":"2026091703485609900_B55","doi-asserted-by":"publisher","first-page":"3950.e25","DOI":"10.1016\/j.cell.2022.09.019","article-title":"State-selective modulation of heterotrimeric G\u03b1s signaling with macrocyclic peptides","volume":"185","author":"Dai","year":"2022","journal-title":"Cell"},{"key":"2026091703485609900_B56","doi-asserted-by":"publisher","first-page":"12060","DOI":"10.3390\/ijms262412060","article-title":"Peptidylarginine deiminases: an overview of recent advances in citrullination research","volume":"26","author":"Kijak-Bo\u0107kowska","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"2026091703485609900_B57","doi-asserted-by":"publisher","first-page":"4761","DOI":"10.1038\/s41467-025-59960-3","article-title":"An mRNA-display derived cyclic peptide scaffold reveals the substrate binding interactions of an N-terminal cysteine oxidase","volume":"16","author":"Jiramongkol","year":"2025","journal-title":"Nat. Commun."},{"key":"2026091703485609900_B58","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1161\/01.RES.0000134924.89412.70","article-title":"Novel mechanism of action for hydralazine","volume":"95","author":"Knowles","year":"2004","journal-title":"Circ. Res."},{"key":"2026091703485609900_B59","doi-asserted-by":"publisher","first-page":"14773","DOI":"10.1038\/ncomms14773","article-title":"Highly selective inhibition of histone demethylases by de novo macrocyclic peptides","volume":"8","author":"Kawamura","year":"2017","journal-title":"Nat. Commun."},{"key":"2026091703485609900_B60","doi-asserted-by":"publisher","first-page":"e202400682","DOI":"10.1002\/cmdc.202400682","article-title":"Targeting N-methyl-lysine histone demethylase KDM4 in cancer: natural products inhibitors as a driving force for epigenetic drug discovery","volume":"20","author":"Cursaro","year":"2025","journal-title":"Chem. Med. Chem."},{"key":"2026091703485609900_B61","doi-asserted-by":"publisher","first-page":"10800","DOI":"10.1039\/D3SC04083F","article-title":"A cell-active cyclic peptide targeting the Nrf2\/Keap1 protein-protein interaction","volume":"14","author":"Iegre","year":"2023","journal-title":"Chem. Sci."},{"key":"2026091703485609900_B62","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1002\/med.21925","article-title":"KEAP1-NRF2 protein-protein interaction inhibitors: Design, pharmacological properties and therapeutic potential","volume":"43","author":"Crisman","year":"2023","journal-title":"Med. Res. Rev."},{"key":"2026091703485609900_B63","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1039\/D0CB00179A","article-title":"In vivo modulation of ubiquitin chains by N -methylated non-proteinogenic cyclic peptides","volume":"2","author":"Rogers","year":"2021","journal-title":"RSC Chem. Biol."},{"key":"2026091703485609900_B64","doi-asserted-by":"publisher","first-page":"6783","DOI":"10.1038\/s41467-021-27032-x","article-title":"Human RIPK3 maintains MLKL in an inactive conformation prior to cell death by necroptosis","volume":"12","author":"Meng","year":"2021","journal-title":"Nat. Commun."},{"key":"2026091703485609900_B65","doi-asserted-by":"publisher","first-page":"e2022933118","DOI":"10.1073\/pnas.2022933118","article-title":"The structure of a minimum amyloid fibril core formed by necroptosis-mediating RHIM of human RIPK3","volume":"118","author":"Wu","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2026091703485609900_B66","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1038\/s41418-021-00742-x","article-title":"A toolbox for imaging RIPK1, RIPK3, and MLKL in mouse and human cells","volume":"28","author":"Samson","year":"2021","journal-title":"Cell Death Differ."},{"key":"2026091703485609900_B67","doi-asserted-by":"publisher","first-page":"4288","DOI":"10.1038\/s41467-025-59432-8","article-title":"Structure-based design of potent and selective inhibitors targeting RIPK3 for eliminating on-target toxicity in vitro","volume":"16","author":"Su","year":"2025","journal-title":"Nat. Commun."},{"key":"2026091703485609900_B68","doi-asserted-by":"publisher","first-page":"922","DOI":"10.12688\/f1000research.153670.2","article-title":"A guide to selecting high-performing antibodies for Huntingtin (UniProt ID: P42858) for use in western blot, immunoprecipitation, and immunofluorescence","volume":"13","author":"Fanti","year":"2025","journal-title":"F1000Res"},{"key":"2026091703485609900_B69","doi-asserted-by":"publisher","first-page":"21964","DOI":"10.1038\/s41598-020-76307-8","article-title":"Use of cyclic peptides to induce crystallization: case study with prolyl hydroxylase domain 2","volume":"10","author":"Chowdhury","year":"2020","journal-title":"Sci. Rep."},{"key":"2026091703485609900_B70","doi-asserted-by":"publisher","first-page":"117830","DOI":"10.1016\/j.bmc.2024.117830","article-title":"Structure-activity relationships of middle-size cyclic peptides, KRAS inhibitors derived from an mRNA display","volume":"110","author":"Kage","year":"2024","journal-title":"Bioorg. Med. Chem."},{"key":"2026091703485609900_B71","article-title":"Roche axes 4 Chugai solid tumor assets in early-phase clear-out","author":"Fierce Biotech","year":"2025"},{"key":"2026091703485609900_B72","article-title":"Consolidated financial statements","author":"Chugai Pharmaceutical Co.","year":"2025"},{"key":"2026091703485609900_B73","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-023-36978-z","article-title":"Amide-to-ester substitution as a stable alternative to N-methylation for increasing membrane permeability in cyclic peptides","volume":"14","author":"Hosono","year":"2023","journal-title":"Nat. Commun."},{"key":"2026091703485609900_B74","doi-asserted-by":"publisher","first-page":"25689","DOI":"10.1021\/acs.jmedchem.5c02276","article-title":"Overcoming challenges in the metabolism of peptide therapeutics: strategies and case studies for clinical success","volume":"68","author":"Ma","year":"2025","journal-title":"J. Med. Chem."},{"key":"2026091703485609900_B75","doi-asserted-by":"publisher","first-page":"13581","DOI":"10.1021\/jacs.5c17859","article-title":"Macrocyclic peptides containing an imidazopyridinium (IP+) unit display enhanced passive cell permeability","volume":"148","author":"Li","year":"2026","journal-title":"J. Am. Chem. Soc."},{"key":"2026091703485609900_B76","doi-asserted-by":"publisher","first-page":"5175","DOI":"10.1021\/acs.jmedchem.5c01836","article-title":"PEGASUS: unlocking polarity in cell-permeable cyclic peptides using AI models built on massively parallel biological assays","volume":"69","author":"Baker","year":"2025","journal-title":"J. Med. Chem."},{"key":"2026091703485609900_B77","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1038\/s41589-025-01929-w","article-title":"Accurate de novo design of high-affinity protein-binding macrocycles using deep learning","volume":"21","author":"Rettie","year":"2025","journal-title":"Nat. Chem. Biol."}],"container-title":["Essays in Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/portlandpress.com\/essaysbiochem\/article-pdf\/doi\/10.1042\/EBC20260008\/992140\/ebc-2026-0008c.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/portlandpress.com\/essaysbiochem\/article-pdf\/doi\/10.1042\/EBC20260008\/992140\/ebc-2026-0008c.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T07:49:04Z","timestamp":1789631344000},"score":1,"resource":{"primary":{"URL":"https:\/\/portlandpress.com\/essaysbiochem\/article\/doi\/10.1042\/EBC20260008\/238080\/Expanding-the-chemical-biology-toolbox-cyclic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,17]]},"references-count":77,"URL":"https:\/\/doi.org\/10.1042\/ebc20260008","relation":{},"ISSN":["0071-1365","1744-1358"],"issn-type":[{"value":"0071-1365","type":"print"},{"value":"1744-1358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,17]]},"article-number":"EBC20260008"}}